We applied the Synthego CRISPR-based knockout strategy that is based on a ribonucleoprotein (RNP) mix which contains both sgRNAs oligos and the translated Cas9 protein, and is used to deliver the sgRNAs to the nucleus of target cells via electroporation without the need for virus infection and drug selection. Here, RNPC3 is linked to viral infectious disease.